Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-002161
Accepted
2020-08-17 00:15:29
Documents
1
Effectiveness Date
2020-08-14
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-20-002161.txt   1798
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-242322 | Film No.: 201107814
SIC: 2834 Pharmaceutical Preparations